Background: In plain pelvic X-ray, magnification makes measurement unreliable. The EOS TM (EOS Imaging, Paris France) imaging system is reputed to reproduce patient anatomy exactly, with a lower radiation dose. This, however, has not been assessed according to patient weight, although both magnification and irradiation are known to vary with weight. We therefore conducted a prospective comparative study, to compare: (1) image magnification and (2) radiation dose between the EOS imaging system and plain X-ray. Hypothesis: The EOS imaging system reproduces patient anatomy exactly, regardless of weight, unlike plain X-ray. Material and method: A single-center comparative study of plain pelvic X-ray and 2D EOS radiography was performed in 183 patients: 186 arthroplasties; 104 male, 81 female; mean age 61.3 ± 13.7 years (range, 24-87 years). Magnification and radiation dose (dose-area product [DAP]) were compared between the two systems in 186 hips in patients with a mean body-mass index (BMI) of 27.1 ± 5.3 kg/m 2 (range, 17.6-42.3 kg/m 2 ), including 7 with morbid obesity. Results: Mean magnification was zero using the EOS system, regardless of patient weight, compared to 1.15 ± 0.05 (range, 1-1.32) on plain X-ray (P < 10 −5 ). In patients with BMI < 25, mean magnification on plain X-ray was 1.15 ± 0.05 (range, 1-1.25) and, in patients with morbid obesity, 1.22 ± 0.06 (range, 1.18-1.32). The mean radiation dose was 8.19 ± 2.63 dGy/cm 2 (range, 1.77-14.24) with the EOS system, versus 19.38 ± 12.37 dGy/cm 2 (range, 4.77-81.75) with plain X-ray (P < 10 −4 ). For BMI >40, mean radiation dose was 9.36 ± 2.57 dGy/cm 2 (range, 7.4-14.2) with the EOS system, versus 44.76 ± 22.21 (range, 25.2-81.7) with plain X-ray. Radiation dose increased by 0.20 dGy with each extra BMI point for the EOS system, versus 0.74 dGy for plain X-ray. Conclusion: Magnification did not vary with patient weight using the EOS system, unlike plain X-ray, and radiation dose was 2.5-fold lower. Level of evidence: 3, prospective case-control study.
Introduction
Pelvic X-ray is frequent and necessary, especially in preoperative work-up or follow-up of total hip replacement (THR) [1] [2] [3] . Plain X-ray is generally used, but has several drawbacks, including image magnification (making preoperative planning measurement unreliable) and patient irradiation [4] .
Magnification in plain X-ray varies with patient morphology, leading to error in image analysis [5, 6] . Moreover, the radiation dose is particularly high (40.48 dGy/cm 2 according to the 2010-2012 DRPH/SER report [7] ), especially for overweight patients, for whom images are frequently repeated to improve quality and centering. The EOS TM imaging system (EOS Imaging, Paris, France) is a biplanar or stereo low-dose radiographic system [8] [9] [10] [11] [12] [13] [14] [15] [16] that can be used for precise preoperative 3D THR planning [17, 18] with excellent reproducibility [19, 20] . It can also provide 2D images with quality equal to or better than that of plain radiography [21] .
The EOS system is intended to reproduce anatomy precisely, while reducing radiation dose [22] [23] [24] [25] [26] [27] [28] . This, however, has not been assessed according to patient weight, although it is agreed that this affects both magnification and radiation dose. We therefore conducted a prospective comparative study to assess: • 2D image magnification;
• radiation dose on EOS versus plain X-ray, according to patient weight.
The study hypothesis was that the biplanar EOS system reproduces patient anatomy exactly (without magnification) regardless of patient weight, unlike plain radiography.
Material and method

Patients
A single-center prospective comparative study was performed, comparing magnification in AP pelvic imaging between the EOS system and plain X-ray. All patients undergoing primary THR between September 2014 and April 2015 in our Orthopedic and Traumatology Department were included. Two images were taken during the patient's hospital stay, following usual practice: one immediate postoperative plain X-ray, and one 2D EOS radiograph (single AP standing view) before discharge. Radiation dose for each examination was measured.
Methods
Femoral head diameter was measured using sterEOS software to analyze both EOS images and plain radiographs. Acquisition followed the EOS manufacturer's instructions (200 mA s, 90 kV) and, for plain X-ray, a protocol taking account of patient morphotype to optimize image quality. The X-ray tube was positioned 120 cm from the pelvis.
All images were analyzed by the same observer (LD). The image centered on the femoral head was enlarged and triangulation from the edges of the head defined the head center. Finally, an equatorial measurement was entered in a data sheet (Fig. 1) . These measurements were then compared according to technique (plain X-ray or EOS system) and body-mass index (BMI).
Assessment methods
The following imaging data were collected:
• radiation dose (dose-area product [DAP]) in dGy/cm 2 , noted on the image; • femoral head diameter in mm, noted in the surgery report;
• image magnification of the head compared to the real implant diameter, calculated as magnification = measured/implanted diameter.
Statistics
Data were entered in an Excel spread-sheet (Microsoft TM ; Redmond, WA). All analyses were performed by an independent statistician, using R freeware version 3.1.1 (R Foundation for Statistical Computing, Vienna, Austria). The significance threshold was set at 5%. Quantitative variables were expressed as mean ± standard deviation for normal distributions meeting the criteria for the Student t test for matched series, and otherwise as median (interquartile range) for the Wilcoxon test for matched series.
Results
Among the 263 arthroplasties performed between September 2014 and April 2015, 76 patients did not have EOS imaging, because they could not remain upright for the examination, could not get into the apparatus, or refused. Data were thus collected for 183 patients:
• 104 male, 81 female; 186 THRs;
• mean age at THR, 61.3 ± 13.7 years (range, 24-87 years);
• mean weight was 76.0 ± 16.7 kg (range, 37-130 kg);
• mean BMI was 27.1 ± 5.3 kg/m 2 (range, 17.6-42.4 kg/m 2 ).
Seven patients (3.8%) showed morbid obesity (BMI ≥ 40), 35 (18.8%) were obese (30 ≤ BMI < 40), and 73 (39.2%) overweight (25 ≤ BMI < 30). Table 1 shows femoral head diameters.
In the EOS group, magnification was zero in 182 cases (97.8%); in the other 4 (2.2%), measured diameter differed from real diameter by 1 mm, for magnifications of 0.96 to 1.04. All patients with morbid obesity showed magnification = 1. There was no significant difference between measured and real head diameter on the EOS system (Fig. 2) . In the plain X-ray group, magnification was zero in 3 cases and otherwise always greater than 1: mean magnification, 1.15 ± 0.05 (range, 1-1.32). Table 2 shows magnification according to BMI; as seen in Fig. 3 , scatter was greater than in the EOS 
Table 2
Percentage magnification according to body-mass index with the EOS system and plain X-ray.
EOS magnification (%) Plain X-ray magnification group. The difference in mean measured versus real diameter was significant: 35 ± 3.6 mm versus 30.3 ± 2.8 mm (P < 0.0001).
The Spearman rank correlation coefficient between magnification on plain X-ray and BMI was 0.14 (P = 0.10). On linear regression, there was 0.17% magnification per extra BMI point (P = 0.057). No such magnification was found in the EOS group.
For radiation exposure, in the EOS group mean DAP was 8.19 ± 2.63 dGy/cm 2 (range, 1.77-14.24 dGy/cm 2 ), compared to 19.38 ± 12.34 dGy/cm 2 (range, 4.27-81.75 dGy/cm 2 ) for plain X-ray (P < 0.0001). Radiation dose with both the EOS system and plain Xray varied with BMI (Table 3 ). Linear regression showed that the dose increased by 0.74 dGy/cm 2 per BMI point in the plain X-ray group, versus 0.20 dGy/cm 2 in the EOS group (P < 0.001). 
Discussion
The present study confirmed that, independently of patient weight, the EOS imaging system does not magnify the image, unlike plain X-ray. Moreover, it delivered a significantly lower radiation dose during AP pelvic imaging.
The study had several limitations:
• intra-and inter-observer radiographic measurement reproducibility were not tested; this would have added value to the results, but the reproducibility of EOS measurements has already been demonstrated [8, 19, 20] ; • the number of subjects statistically required to prove the study hypothesis was not calculated; but the series was quite large, with a balanced sex-ratio and normal distribution of BMI; • the EOS system was not assessed in the context of preoperative planning. However, the study involved a significant number of THRs, enhancing statistical power. Using prosthetic femoral head measurement to assess radiographic magnification is common and reliable [29] [30] [31] [32] .
Variable magnification on plain X-ray is a recognized physical principle [33] , stimulating radiologists to improve their equipment and learn to take magnification into account in interpreting their findings. In orthopedics, having an optimally reliable image without magnification or deformation is primordial, especially in preoperative planning. The problem of magnification in the planning context has been demonstrated, with risk of numerous errors in selecting implant size [34, 35] despite standardized radiology protocols with predefined source-plate-patient distances, intended to ensure constant magnification [36, 37] . To avoid these problems and ensure correct preoperative planning, the image has to be calibrated so that the implant manufacturer's template, enlarged to 110, 115 or 120%, can be used. Calibration uses an object of known size as reference [5, 30, 38, 39] , but raises problems of its own, especially regarding the ideal positioning of anteroposterior and mediolateral markers to match hip anatomy and come as close as possible to the area of interest: i.e., the center of rotation of the hip. Moreover, some authors report problems of tact or embarrassment, especially in obese patients, as markers are mainly positioned between the legs [31, 38] . The present study found that one extra BMI point led to 0.17% greater magnification: that is, 1.7% for 10 BMI points, which is of no great clinical impact. The EOS avoided these issues, as magnification was zero; 4 patients showed just 1 mm magnification with respect to real implant size, without correlation with BMI, and possibly due to the patients moving during image-taking.
Radiation dose was measured as DAP rather than entrance skin exposure (ESE) as the former is more straightforward and available on all radiographs, unlike ESE. DAP corresponds better to global dose for an examination, whereas ESE corresponds more to the dose received by an organ. These measures are widely used and reliable for assessing irradiation [40] . The present mean values for an imaging examination differ from those found in the literature; Dubousset et al. [8] showed that the EOS involved 8-to-10-fold less radiation than plain X-ray, and Deschênes et al. [21] 6-to-9-fold less, compared to about 2.5-fold less in the present series. This is probably due to progress in plain X-ray delivery [41] . Also, dosimetry differed, the above-mentioned studies using ESE and the present study DAP. Although the present results seem to indicate a significant correlation between radiation dose using the EOS system and BMI, but the low doses involved in EOS imaging are to be borne in mind, with a maximum dose in morbidly obese patients still well lower than the general mean dose in plain X-ray and always less than 10 dGy/cm 2 .
Mean radiation dose for plain AP pelvic X-ray was just under 20 dGy/cm 2 , well below the Nuclear Safety Agency's threshold of 70 dGy/cm 2 . For obese or morbidly obese patients, however, the dose was closer to threshold. This over-exposure of obese patients was previously reported, with a variety of possible preventive measures [42] . In the present series, with the EOS system there seemed to be a slight increase in dose with increasing BMI, as explained above, but nothing like the increase with plain X-ray, which was slightly more than 0.7 dGy/cm 2 per extra BMI point (Fig. 4) . Moreover, in certain conventional examinations, especially in obese patients, several images may need to be taken to optimize quality and centering. In these patients, over-exposure is not just a question of the imaging technique but also of iterative imaging. In the literature, many studies directly or indirectly mention radiation effects on the organism [43] , and always stress the need to justify each medical imaging examination, optimize equipment and limit doses in line with guidelines [44] [45] [46] .
Conclusion
The present study confirmed that the EOS imaging system does not lead to magnification in pelvic imaging, regardless of patient morphology, whereas plain X-ray systematically involves magnification, by a mean 1.15 ± 0.05, increasing with increasing patient weight. The EOS system also delivered a significantly lower radiation dose than plain X-ray in all patients, and especially in the overweight, in acquiring an AP segmental pelvic view. If access could be improved, this technique has the qualities required to replace plain X-ray for standing pelvic imaging.
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